|
G |
AGT |
angiotensinogen |
multiple interactions increases secretion |
EXP |
3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer inhibits the reaction [AGT protein results in increased secretion of Aldosterone]; Enkephalin, D-Penicillamine (2,5)- inhibits the reaction [AGT protein results in increased secretion of Aldosterone] |
CTD |
PMID:22100847 |
|
NCBI chr14:59,643,030...59,656,835
Ensembl chr14:59,643,292...59,656,833
|
|
G |
ATP1A1 |
ATPase Na+/K+ transporting subunit alpha 1 |
increases expression |
EXP |
Aldosterone results in increased expression of ATP1A1 protein |
CTD |
PMID:28438630 |
|
NCBI chr 4:104,353,506...104,384,321
Ensembl chr 4:104,353,506...104,384,680
|
|
G |
GCLC |
glutamate-cysteine ligase catalytic subunit |
increases expression |
EXP |
Aldosterone results in increased expression of GCLC protein |
CTD |
PMID:24512358 |
|
NCBI chr 7:27,209,565...27,253,535
Ensembl chr 7:27,209,565...27,253,530
|
|
G |
HMOX1 |
heme oxygenase 1 |
increases expression |
EXP |
Aldosterone results in increased expression of HMOX1 protein |
CTD |
PMID:24512358 |
|
|
|
G |
NFE2L2 |
NFE2 like bZIP transcription factor 2 |
multiple interactions |
EXP |
1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester inhibits the reaction [Aldosterone results in increased activity of NFE2L2 protein]; 3-benzyl-7-(2-benzoxazolyl)thio-1,2,3-triazolo(4,5-d)pyrimidine inhibits the reaction [Aldosterone results in increased activity of NFE2L2 protein]; acetovanillone inhibits the reaction [Aldosterone results in increased activity of NFE2L2 protein]; Acetylcysteine inhibits the reaction [Aldosterone results in increased activity of NFE2L2 protein]; Aldosterone results in increased expression of and results in increased activity of NFE2L2 protein; diphenyleneiodonium inhibits the reaction [Aldosterone results in increased activity of NFE2L2 protein]; Eplerenone inhibits the reaction [Aldosterone results in increased activity of NFE2L2 protein]; Ro 32-0432 inhibits the reaction [Aldosterone results in increased activity of NFE2L2 protein]; tempol inhibits the reaction [Aldosterone results in increased activity of NFE2L2 protein]; Thioctic Acid inhibits the reaction [Aldosterone results in increased activity of NFE2L2 protein]; W 7 inhibits the reaction [Aldosterone results in increased activity of NFE2L2 protein] |
CTD |
PMID:24512358 |
|
NCBI chr15:82,967,485...83,146,185
Ensembl chr15:82,973,656...83,146,183
|
|
G |
SOD1 |
superoxide dismutase 1 |
increases expression |
EXP |
Aldosterone results in increased expression of SOD1 protein |
CTD |
PMID:24512358 |
|
NCBI chr13:195,326,573...195,335,273
Ensembl chr13:195,326,649...195,337,729
|
|
G |
TXNRD1 |
thioredoxin reductase 1 |
increases expression |
EXP |
Aldosterone results in increased expression of TXNRD1 protein |
CTD |
PMID:24512358 |
|
NCBI chr 5:80,170,334...80,213,889
Ensembl chr 5:80,172,260...80,236,219
|
|
|
G |
AGT |
angiotensinogen |
increases secretion |
EXP |
AGT protein results in increased secretion of Progesterone |
CTD |
PMID:22100847 |
|
NCBI chr14:59,643,030...59,656,835
Ensembl chr14:59,643,292...59,656,833
|
|
G |
CRABP1 |
cellular retinoic acid binding protein 1 |
affects expression |
EXP |
Progesterone affects the expression of CRABP1 protein |
CTD |
PMID:11833939 |
|
NCBI chr 7:47,602,316...47,608,865
Ensembl chr 7:47,602,192...47,608,970
|
|
G |
CST3 |
cystatin C |
affects expression |
EXP |
Progesterone affects the expression of CST3 mRNA |
CTD |
PMID:20107207 |
|
NCBI chr17:30,471,056...30,474,486
Ensembl chr17:30,470,855...30,474,590
|
|
G |
CTSB |
cathepsin B |
increases expression |
EXP |
Progesterone results in increased expression of CTSB mRNA |
CTD |
PMID:20107207 |
|
NCBI chr14:15,014,139...15,035,081
Ensembl chr14:15,011,711...15,033,877
|
|
G |
CTSL |
cathepsin L |
increases expression |
EXP |
Progesterone results in increased expression of CTSL mRNA |
CTD |
PMID:20107207 |
|
NCBI chr10:27,668,523...27,674,705
Ensembl chr10:27,668,264...27,674,618
|
|
G |
EGFR |
epidermal growth factor receptor |
affects chemical synthesis |
EXP |
EGFR protein affects the chemical synthesis of Progesterone |
CTD |
PMID:21520325 |
|
NCBI chr 9:139,302,410...139,474,632
Ensembl chr 9:139,300,022...139,475,589
|
|
G |
FGF2 |
fibroblast growth factor 2 |
multiple interactions |
EXP |
Progesterone inhibits the reaction [estrone benzoate results in decreased expression of FGF2 mRNA] |
CTD |
PMID:15120423 |
|
NCBI chr 8:101,278,877...101,344,084
Ensembl chr 8:101,278,885...101,343,916
|
|
G |
FGFR1 |
fibroblast growth factor receptor 1 |
multiple interactions decreases expression |
EXP |
estrone benzoate inhibits the reaction [Progesterone results in decreased expression of FGFR1 mRNA alternative form] |
CTD |
PMID:15120423 |
|
NCBI chr15:48,053,895...48,106,634
Ensembl chr15:48,053,340...48,106,724
|
|
G |
FGFR2 |
fibroblast growth factor receptor 2 |
decreases expression multiple interactions |
EXP |
Progesterone results in decreased expression of FGFR2 mRNA alternative form [Progesterone co-treated with estradiol 3-benzoate] results in decreased expression of FGFR2 mRNA alternative form |
CTD |
PMID:15120423 PMID:15976484 |
|
NCBI chr14:131,183,095...131,285,001
Ensembl chr14:131,181,713...131,289,425
|
|
G |
FSHB |
follicle stimulating hormone subunit beta |
increases chemical synthesis multiple interactions increases abundance |
EXP |
FSHB protein results in increased chemical synthesis of Progesterone 4,4'-bisphenol F inhibits the reaction [FSHB protein results in increased chemical synthesis of and results in increased secretion of Progesterone]; 4,4'-hexafluorisopropylidene diphenol inhibits the reaction [FSHB protein results in increased chemical synthesis of and results in increased secretion of Progesterone]; [FSHB protein co-treated with IGF1 protein] results in increased abundance of Progesterone; [FSHB protein co-treated with Lead co-treated with Mercury] results in decreased secretion of Progesterone; bisphenol A inhibits the reaction [FSHB protein results in increased chemical synthesis of and results in increased secretion of Progesterone]; bisphenol A promotes the reaction [fisetin inhibits the reaction [FSHB protein results in increased chemical synthesis of and results in increased secretion of Progesterone]]; bisphenol S inhibits the reaction [FSHB protein results in increased chemical synthesis of and results in increased secretion of Progesterone]; deoxynivalenol inhibits the reaction [[FSHB protein co-treated with IGF1 protein] results in increased abundance of Progesterone]; fisetin inhibits the reaction [FSHB protein results in increased chemical synthesis of and results in increased secretion of Progesterone]; fisetin promotes the reaction [bisphenol A inhibits the reaction [FSHB protein results in increased chemical synthesis of and results in increased secretion of Progesterone]]; FSHB protein results in increased chemical synthesis of and results in increased secretion of Progesterone; Lapatinib inhibits the reaction [FSHB protein results in increased abundance of Progesterone]; Zearalenone promotes the reaction [FSHB protein results in increased abundance of Progesterone] |
CTD |
PMID:17656051 PMID:20390873 PMID:20965553 PMID:23375200 PMID:29544186 PMID:34019995 More...
|
|
NCBI chr 2:30,395,769...30,399,282
Ensembl chr 2:30,395,018...30,399,274
|
|
G |
GHRL |
ghrelin and obestatin prepropeptide |
multiple interactions decreases secretion increases secretion |
EXP |
Aminoglutethimide promotes the reaction [GHRL protein results in decreased secretion of Progesterone]; GHRL protein results in decreased chemical synthesis of and results in decreased secretion of Progesterone; STAT1 protein inhibits the reaction [GHRL protein results in decreased secretion of Progesterone] GHRL protein results in increased secretion of Progesterone |
CTD |
PMID:17904772 PMID:19528263 PMID:22341706 |
|
NCBI chr13:66,442,106...66,453,576
Ensembl chr13:66,445,992...66,452,917
|
|
G |
HOXA10 |
homeobox A10 |
increases expression multiple interactions |
EXP |
Progesterone results in increased expression of HOXA10 mRNA Estradiol promotes the reaction [Progesterone results in increased expression of HOXA10 mRNA] |
CTD |
PMID:21705055 |
|
NCBI chr18:45,393,525...45,403,259
Ensembl chr18:45,393,885...45,403,257
|
|
G |
IGF1 |
insulin like growth factor 1 |
multiple interactions increases abundance |
EXP |
[FSHB protein co-treated with IGF1 protein] results in increased abundance of Progesterone; deoxynivalenol inhibits the reaction [[FSHB protein co-treated with IGF1 protein] results in increased abundance of Progesterone]; Zearalenone promotes the reaction [IGF1 protein results in increased abundance of Progesterone] |
CTD |
PMID:17656051 |
|
NCBI chr 5:81,762,027...81,909,253
Ensembl chr 5:81,775,970...81,848,033
|
|
G |
LEP |
leptin |
multiple interactions increases secretion increases expression |
EXP |
[TP53 protein co-treated with LEP protein] results in increased secretion of Progesterone Progesterone results in increased secretion of LEP protein Progesterone results in increased expression of LEP mRNA |
CTD |
PMID:22151798 PMID:23153703 |
|
NCBI chr18:20,106,867...20,124,071
Ensembl chr18:20,106,868...20,123,323
|
|
G |
LHB |
luteinizing hormone subunit beta |
increases abundance multiple interactions |
EXP |
LHB protein results in increased abundance of Progesterone daidzein inhibits the reaction [LHB protein results in increased abundance of Progesterone]; Lapatinib inhibits the reaction [LHB protein results in increased abundance of Progesterone] |
CTD |
PMID:19617652 PMID:23375200 |
|
NCBI chr 6:54,263,574...54,269,286
Ensembl chr 6:54,263,576...54,271,086
|
|
G |
OXT |
oxytocin/neurophysin I prepropeptide |
multiple interactions |
EXP |
Progesterone affects the reaction [OXT protein results in increased abundance of Calcium]; Progesterone inhibits the reaction [OXT protein results in increased abundance of Dinoprost]; Progesterone inhibits the reaction [OXT protein results in increased secretion of Dinoprost]; Progesterone inhibits the reaction [OXT protein results in increased secretion of Dinoprostone]; Progesterone inhibits the reaction [OXT protein results in increased transport of Calcium] |
CTD |
PMID:16997130 PMID:21370738 |
|
NCBI chr17:32,605,586...32,606,449
Ensembl chr17:32,605,586...32,606,546
|
|
G |
PLAU |
plasminogen activator, urokinase |
increases expression |
EXP |
Progesterone results in increased expression of PLAU mRNA |
CTD |
PMID:23103014 |
|
NCBI chr14:76,629,313...76,635,173
Ensembl chr14:76,629,299...76,635,172
|
|
G |
POMC |
proopiomelanocortin |
increases secretion |
EXP |
POMC protein results in increased secretion of Progesterone |
CTD |
PMID:22100847 |
|
NCBI chr 3:113,661,712...113,668,558
Ensembl chr 3:113,661,004...113,670,418
|
|
G |
RBP4 |
retinol binding protein 4 |
affects expression |
EXP |
Progesterone affects the expression of RBP4 protein |
CTD |
PMID:11833939 |
|
NCBI chr14:105,037,360...105,044,552
Ensembl chr14:105,037,464...105,044,765
|
|
G |
STAT1 |
signal transducer and activator of transcription 1 |
multiple interactions |
EXP |
STAT1 protein inhibits the reaction [GHRL protein results in decreased secretion of Progesterone] |
CTD |
PMID:19528263 |
|
NCBI chr15:95,593,201...95,646,324
Ensembl chr15:95,593,211...95,646,260
|
|
G |
TP53 |
tumor protein p53 |
multiple interactions decreases secretion |
EXP |
[TP53 protein co-treated with LEP protein] results in increased secretion of Progesterone TP53 protein results in decreased secretion of Progesterone |
CTD |
PMID:22151798 |
|
NCBI chr12:52,939,643...52,953,786
Ensembl chr12:52,939,644...52,953,818
|
|